Year-over-year earnings per share growth for the last twelve months: reviveprocare.com (AXIL)

Corporate emblem and logo of AXIL Brands (AXIL)

The success of AXIL Brands, Inc. (AXIL) relies on the recognition of niche brands and the efficiency of online marketing. The quarterly earnings per share growth rate visualizes this dependency, where 25.50 shows the current volume of the metric. Stable demand for dermatological products mitigates inflationary risks, while an organic portfolio renewal strategy and cash flow optimization strengthen the business's internal resilience.

AXIL Brands Inc (AXIL) - Quarterly EPS earnings growth from 02/21/2024 to 11/12/2026

Summary analytical data breakdowns for AXIL Brands, Inc. (AXIL)

- share price and expert price forecast:
Stock Price reviveprocare.com|AXIL - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value AXIL|AXIL - Business Value
- book capitalization data:
Book Value per Share AXIL Brands|AXIL - Book Capitalization|Market Cap to Net Assets Ratio reviveprocare.com|AXIL - Total Business Assets
- debt and solvency information:
Total Debt to Capital AXIL Brands, Inc.|AXIL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity reviveprocare.com|AXIL - Company Debts|Debt to Book Value AXIL|AXIL - Company Long-Term Loans and Borrowings|Company Short-Term Debts AXIL Brands|Quick Liquidity reviveprocare.com
- earnings and valuation multiples indicators:
AXIL - Final Profit|Projected Future Earnings AXIL Brands, Inc.|AXIL - P/E Multiple|Future Price to Earnings reviveprocare.com|AXIL - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple AXIL|AXIL - Operating profit before amortization|Earnings per share for the last twelve months AXIL Brands|AXIL - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months reviveprocare.com|AXIL - Earnings per share increase in current year|Earnings growth forecast for next year AXIL Brands, Inc.
Fundamental valuation:AXIL Brands Inc, AXIL
Flagship merchandise of reviveprocare.com

The operational resilience of AXIL Brands, Inc. (AXIL) is based on stable demand from beauty salons for the Inertia line, as reflected in the quarterly earnings per share history. The current value of 25.50 captures the real growth in net income per share, allowing investors to filter out market noise and assess the fundamental value of the business through the lens of effective consumer loyalty monetization.

Who AXIL Brands, Inc. competes with

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics Inc|Year-over-year earnings per share growth for the last 12 months VCEL (Vericel Inc.)|Quarterly EPS earnings growth ORKA|Quarterly EPS earnings growth sanaramedtech.com (SMTI)|DBV Technologies - Year-over-year net earnings per share growth for the last 12 months|SLSN: Year-over-year earnings per share growth for the last 12 months|Journey Medical Corp. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Forte Biosciences Inc FBRX|Empro Group Inc (EMPG) - Year-over-year earnings per share growth for the last twelve months|SLGL (sol-gel.com) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months MDCX|VRCA: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HOTH|Year-over-year earnings per share growth for the last twelve months BFRI (biofrontera-us.com)|Year-over-year earnings per share growth for the last twelve months VYNE Therapeutics Inc. VYNE|Year-over-year earnings per one share growth for the last 12 months SNOA|Quoin Pharma - Quarterly EPS earnings growth|AZTR - Quarterly EPS earnings growth|Dermata (DRMA) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ELAB|RVNC (Revance Therapeutics) - Quarterly EPS earnings growth